{"disease":{"id":"hemoglobinopathies","name":"hemoglobinopathies"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05799118","title":"Study of the Role of Genetic Modifiers in Hemoglobinopathies","phase":"","overall_status":"RECRUITING","enrollment_count":30000,"lead_sponsor_name":"Cyprus Institute of Neurology and Genetics","has_results":false},{"nct_id":"NCT07305181","title":"Prevalence of Abnormal Haemoglobin Variants in Metropolitan Chattogram, Bangladesh","phase":"","overall_status":"COMPLETED","enrollment_count":8400,"lead_sponsor_name":"Bangladesh Bioscience Research Group","has_results":false},{"nct_id":"NCT04029142","title":"Screening for Hemoglobinopathies in Pregnant Women","phase":"","overall_status":"COMPLETED","enrollment_count":1785,"lead_sponsor_name":"University Hospital, Basel, Switzerland","has_results":false},{"nct_id":"NCT07180836","title":"Prevalence and Hematological Characteristics of Hemoglobinopathies","phase":"","overall_status":"COMPLETED","enrollment_count":839,"lead_sponsor_name":"Bacha Khan Medical College","has_results":false},{"nct_id":"NCT07207551","title":"Prevalence of Hemoglobinopathies Associated With Significant Hb Variants in the Chattogram Region of Bangladesh","phase":"","overall_status":"COMPLETED","enrollment_count":760,"lead_sponsor_name":"Bangladesh Bioscience Research Group","has_results":false},{"nct_id":"NCT06831799","title":"ERN-EuroBloodNet Registry on Patients With Rare Red Blood Cell Defects and COVID-19","phase":"","overall_status":"COMPLETED","enrollment_count":684,"lead_sponsor_name":"Hospital Universitari Vall d'Hebron Research Institute","has_results":false},{"nct_id":"NCT07227155","title":"The HOPE Biobank Resource (BMT CTN 2402 HOPE)","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":375,"lead_sponsor_name":"Medical College of Wisconsin","has_results":false},{"nct_id":"NCT00102245","title":"Clinical and Laboratory Investigation of Humans With Informative Iron or Erythroid Phenotypes","phase":"","overall_status":"TERMINATED","enrollment_count":334,"lead_sponsor_name":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","has_results":false},{"nct_id":"NCT03149289","title":"Hepatitis C Virus Infection in Patients With Hemoglobinopathies","phase":"","overall_status":"COMPLETED","enrollment_count":168,"lead_sponsor_name":"Società Italiana Talassemie ed Emoglobinopatie","has_results":false},{"nct_id":"NCT04208529","title":"A Long-term Follow-up Study in Participants Who Received CTX001","phase":"PHASE3","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":160,"lead_sponsor_name":"Vertex Pharmaceuticals Incorporated","has_results":false},{"nct_id":"NCT00000588","title":"Chelation Therapy of Iron Overload With Pyridoxal Isonicotinoyl Hydrazone","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":120,"lead_sponsor_name":"Case Western Reserve University","has_results":false},{"nct_id":"NCT05389891","title":"Hemoglobinopathy Nursing Program and Pediatric Nursing Students","phase":"NA","overall_status":"COMPLETED","enrollment_count":108,"lead_sponsor_name":"Beni-Suef University","has_results":false},{"nct_id":"NCT04445402","title":"Pediatrics HOT COVID-19 Database in NY Tristate","phase":"","overall_status":"COMPLETED","enrollment_count":77,"lead_sponsor_name":"Columbia University","has_results":false},{"nct_id":"NCT01316549","title":"Study of Fludarabine Drug Exposure in Pediatric Bone Marrow Transplantation","phase":"","overall_status":"COMPLETED","enrollment_count":67,"lead_sponsor_name":"University of California, San Francisco","has_results":false},{"nct_id":"NCT03745287","title":"A Safety and Efficacy Study Evaluating CTX001 in Subjects With Severe Sickle Cell Disease","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":63,"lead_sponsor_name":"Vertex Pharmaceuticals Incorporated","has_results":false},{"nct_id":"NCT06872333","title":"Allo HSCT for High Risk Hemoglobinopathies","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":62,"lead_sponsor_name":"Masonic Cancer Center, University of Minnesota","has_results":false},{"nct_id":"NCT03655678","title":"A Safety and Efficacy Study Evaluating CTX001 in Participants With Transfusion-Dependent β-Thalassemia","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":59,"lead_sponsor_name":"Vertex Pharmaceuticals Incorporated","has_results":false},{"nct_id":"NCT04644016","title":"Cord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant Disorders","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":31,"lead_sponsor_name":"Memorial Sloan Kettering Cancer Center","has_results":false},{"nct_id":"NCT03609814","title":"Study of Clofarabine and Fludarabine Drug Exposure in Pediatric Bone Marrow Transplantation (HCT)","phase":"","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"University of California, San Francisco","has_results":false},{"nct_id":"NCT06490601","title":"Long Term Beta Thalassemia Treatment: Findings From The Extension Period","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":30,"lead_sponsor_name":"National Institute of Blood and Marrow Transplant (NIBMT), Pakistan","has_results":false},{"nct_id":"NCT05477563","title":"Evaluation of Efficacy and Safety of a Single Dose of CTX001 in Participants With Transfusion-Dependent β-Thalassemia and Severe Sickle Cell Disease","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":26,"lead_sponsor_name":"Vertex Pharmaceuticals Incorporated","has_results":false},{"nct_id":"NCT03609840","title":"Study of Thiotepa and TEPA Drug Exposure in Pediatric Hematopoietic Stem Cell Transplant Patients","phase":"","overall_status":"COMPLETED","enrollment_count":25,"lead_sponsor_name":"University of California, San Francisco","has_results":false},{"nct_id":"NCT03609827","title":"Study of Melphalan Drug Exposure in Pediatric Hematopoietic Stem Cell Transplant Patients","phase":"","overall_status":"COMPLETED","enrollment_count":25,"lead_sponsor_name":"University of California, San Francisco","has_results":false},{"nct_id":"NCT07190001","title":"YOLT-204 in Patients With Hemoglobinopathies","phase":"EARLY_PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":18,"lead_sponsor_name":"Guangzhou Women and Children's Medical Center","has_results":false},{"nct_id":"NCT05356195","title":"Evaluation of Safety and Efficacy of CTX001 in Pediatric Participants With Transfusion-Dependent β-Thalassemia (TDT)","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":16,"lead_sponsor_name":"Vertex Pharmaceuticals Incorporated","has_results":false},{"nct_id":"NCT05329649","title":"Evaluation of Safety and Efficacy of CTX001 in Pediatric Participants With Severe Sickle Cell Disease (SCD)","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":13,"lead_sponsor_name":"Vertex Pharmaceuticals Incorporated","has_results":false},{"nct_id":"NCT02986698","title":"In Utero Hematopoietic Stem Cell Transplantation for Alpha-thalassemia Major (ATM)","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":6,"lead_sponsor_name":"University of California, San Francisco","has_results":false},{"nct_id":"NCT06107400","title":"Safety and Efficacy of RM-004 Cells for Hemoglobin H-Constant Spring Disease","phase":"EARLY_PHASE1","overall_status":"RECRUITING","enrollment_count":5,"lead_sponsor_name":"The 923rd Hospital of Joint Logistics Support Force of People's Liberation Army","has_results":false},{"nct_id":"NCT03249831","title":"A Blood Stem Cell Transplant for Sickle Cell Disease","phase":"PHASE1","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":3,"lead_sponsor_name":"City of Hope Medical Center","has_results":false},{"nct_id":"NCT05236764","title":"Haploidentical Hematopoietic Cell Transplantation Using TCR Alpha/Beta and CD19 Depletion","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":3,"lead_sponsor_name":"Baylor College of Medicine","has_results":true}],"total":30},"guidelines":[],"source":"Drug Landscape verified database"}